Related Experiment Video
Updated: Feb 12, 2026

Intracranial Implantation with Subsequent 3D In Vivo Bioluminescent Imaging of Murine Gliomas
Published on: November 6, 2011
Targeted therapy of intracranial glioma model mice with curcumin nanoliposomes
Ming Zhao1, Mengnan Zhao1, Chen Fu1
1School of Pharmaceutical Sciences, Southwest University, Chongqing, People's Republic of China.
Background:
Glioma is the most aggressive and lethal brain tumor in humans, it comprises about 30 per cent of all brain tumors and central nervous system tumors.
Purpose:
The objective of this study was to create novel brain-targeting nanoliposomes to encapsulate curcumin as a promising option for glioma therapy.
Patients And Methods:
Human glioma cells (U251MG) were used to determine cell uptake efficiency and possible internalization mechanism of the curcumin-loaded nanoliposomes modified by a brain-targeting peptide RDP. In addition, intracranial glioma mice model was prepared by transplantation of U251MG cells into the mice striatum, and then the liposomes were intravenously administered into the glioma-bearing mice to evaluate the anti-glioma activity.
Results:
RDP-modified liposomes (RCL) could enter the brain and glioma region, and were internalized by the glioma cells perhaps through acetylcholine receptor-mediated endocytosis pathway. Furthermore, the RCL prolonged the survival time of the glioma-bearing mice from 23 to 33 days, and the inhibition mechanism of the RCL on glioma cell was partly due to cell cycle arrest at the S phase and induction of cell apoptosis.
Conclusion:
This study would provide a potential approach for targeted delivery of drug-loaded liposomes for glioma treatment.
Insights
Novel brain-targeting nanoliposomes loaded with curcumin effectively treated glioma in mice. These RDP-modified liposomes (RCL) improved survival by targeting brain tumors and inducing cell death.
Area of Science:
- Nanomedicine
- Biotechnology
- Oncology
Background:
- Glioma is a highly aggressive and lethal brain tumor, accounting for 30% of all brain and central nervous system tumors.
- Effective therapeutic strategies for glioma remain a significant challenge in neuro-oncology.
Purpose of the Study:
- To develop novel brain-targeting nanoliposomes for encapsulating curcumin, a potential glioma therapeutic agent.
- To enhance curcumin delivery to brain tumors using targeted nanoliposomes.
Main Methods:
- Human glioma cells (U251MG) were used to assess the cellular uptake and internalization mechanisms of curcumin-loaded nanoliposomes modified with the RDP brain-targeting peptide.
- An intracranial glioma mouse model was established, and RDP-modified liposomes (RCL) were administered intravenously to evaluate anti-glioma activity.
Main Results:
- RDP-modified liposomes (RCL) demonstrated brain penetration and accumulation in the glioma region.
- Glioma cells internalized RCL, potentially via acetylcholine receptor-mediated endocytosis.
- RCL treatment significantly prolonged survival in glioma-bearing mice (from 23 to 33 days).
- RCL inhibited glioma cell growth through cell cycle arrest at the S phase and induced apoptosis.
Conclusions:
- This study presents a promising strategy for targeted delivery of liposomal drugs for enhanced glioma treatment.
- RDP-modified nanoliposomes offer a potential platform for improving the efficacy of curcumin-based glioma therapies.
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against...
Modeling in Therapy
Participant Modeling
Participant modeling involves therapists demonstrating calm and effective behaviors in...
Gene Therapy
Group Therapy
Behavior Therapy
Exposure therapy is a cornerstone of behavioral treatment for anxiety disorders. It involves systematic exposure to feared stimuli, either in real...
Drug Therapy
Antianxiety Medications

